$93.8 Million is the total value of Data Collective IV GP, LLC's 6 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 66.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RXRX | Recursion Pharmaceuticals, Inc. | $39,627,270 | -13.5% | 5,941,120 | 0.0% | 42.23% | -12.2% | |
| Evolv Technologies Holdings, Inc. | $33,075,997 | +20.5% | 10,601,281 | 0.0% | 35.25% | +22.2% | ||
| New | Rocket Lab USA, Inc. | $11,834,574 | – | 2,929,350 | +100.0% | 12.61% | – | |
| Sell | Embark Technology, Inc. | $8,952,680 | -14.6% | 3,186,007 | -0.0% | 9.54% | -13.3% | |
| New | Mind Medicine (MindMed) Inc. | $318,110 | – | 100,350 | +100.0% | 0.34% | – | |
| Sell | Roivant Sciences Ltd. | $28,598 | -86.1% | 3,875 | -85.0% | 0.03% | -86.2% | |
| MNMD | Exit | Mind Medicine (MindMed) Inc. | $0 | – | -100,350 | -100.0% | -0.23% | – |
| Exit | Rocket Lab USA, Inc. | $0 | – | -2,929,350 | -100.0% | -11.60% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Recursion Pharmaceuticals, Inc. | 8 | Q3 2023 | 50.0% |
| Evolv Technologies Holdings, Inc. | 8 | Q3 2023 | 47.1% |
| Rocket Lab USA, Inc. | 5 | Q4 2022 | 11.6% |
| Mind Medicine (MindMed) Inc. | 5 | Q4 2022 | 4.1% |
| Embark Trucks, Inc. | 4 | Q2 2023 | 18.7% |
| Roivant Sciences Ltd. | 4 | Q3 2023 | 0.2% |
| Embark Trucks, Inc. | 3 | Q2 2022 | 79.7% |
| Rocket Lab USA, Inc. | 3 | Q3 2023 | 13.0% |
| Mind Medicine (MindMed) Inc. | 3 | Q3 2023 | 0.3% |
View Data Collective IV GP, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR/A | 2022-11-14 |
| 4 | 2022-09-01 |
View Data Collective IV GP, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.